ArticleTherapeutic advances in medical oncology2025

Comparative analysis of alectinib and brigatinib in real-world treatment of advanced NSCLC with ALK rearrangements.

Kyuhwan Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.